gusperimus has been researched along with Leukocytopenia in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (57.14) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Birck, R; Choi, M; Drexler, JM; Göbel, U; Grünke, M; Haubitz, M; Hotta, O; Kalden, JR; Lorenz, HM; Nowack, R; Peter, HH; Van Der Woude, FJ; Warnatz, K | 1 |
| Birck, R; Choi, M; Göbel, U; Heinzel, PA; Peter, HH; Schmitt, WH; van der Woude, FJ; Warnatz, K | 1 |
| Akamatsu, Y; Enomoto, Y; Kawagishi, N; Satoh, K; Satomi, S; Sekiguchi, S | 1 |
| Fujii, Y; Han, M; Hashino, S; Imai, K; Imamura, M; Kobayashi, H; Kobayashi, M; Kobayashi, S; Tanaka, J; Zhu, X | 1 |
| Inagaki, J; Kimura, I; Majima, H; Masaoka, T; Niitani, H; Oguro, M; Ohno, R; Sanpi, K; Suzuoki, Y; Tamura, K | 1 |
| Abe, F; Ito, J; Nemoto, K; Ogino, M; Sugawara, Y; Takeuchi, T | 1 |
| Chiba, S; Furuta, T; Hotta, O; Ito, K; Taguma, Y | 1 |
2 trial(s) available for gusperimus and Leukocytopenia
| Article | Year |
|---|---|
Phase I study of NKT-01.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Dose-Response Relationship, Drug; Female; Guanidines; Hemoglobins; Humans; Leukemia; Leukocyte Count; Leukopenia; Lymphoma; Male; Middle Aged; Multiple Myeloma; Neoplasms; Platelet Count; Regression Analysis | 1995 |
[Effects of deoxyspergualin on proliferative glomerulonephritis].
Topics: Adult; Female; Glomerulonephritis; Guanidines; Humans; Immunosuppressive Agents; Infusions, Intravenous; Leukopenia; Male; Middle Aged; Proteinuria | 1999 |
5 other study(ies) available for gusperimus and Leukocytopenia
| Article | Year |
|---|---|
15-Deoxyspergualin in patients with refractory ANCA-associated systemic vasculitis: a six-month open-label trial to evaluate safety and efficacy.
Topics: Adult; Aged; Antibodies, Antineutrophil Cytoplasmic; Drug Administration Schedule; Female; Granulomatosis with Polyangiitis; Guanidines; Humans; Immunosuppressive Agents; Leukocyte Count; Leukopenia; Male; Middle Aged; Pilot Projects; Safety; Solitary Pulmonary Nodule; Tomography, X-Ray Computed; Treatment Outcome; Vasculitis | 2003 |
Prolonged treatment of refractory Wegener's granulomatosis with 15-deoxyspergualin: an open study in seven patients.
Topics: Adult; Aged; Female; Granulomatosis with Polyangiitis; Guanidines; Humans; Immunosuppressive Agents; Leukopenia; Male; Middle Aged; Remission Induction | 2005 |
Usage of deoxyspergualin on steroid-resistant acute rejection in living donor liver transplantation.
Topics: ABO Blood-Group System; Acute Disease; Blood Component Removal; Blood Group Incompatibility; Child; Child, Preschool; Female; Follow-Up Studies; Graft Rejection; Granulocyte Colony-Stimulating Factor; Guanidines; Humans; Immunosuppressive Agents; Infant; Leukopenia; Liver Transplantation; Living Donors; Male; Platelet Transfusion; Retrospective Studies; Thrombocytopenia; Time Factors; Treatment Outcome | 2006 |
In vivo effects of the immunosuppressant 15-deoxyspergualin on hematopoiesis in murine allogeneic bone marrow chimeras. Its thrombopoietic activity and reversal of adverse effects with granulocyte colony-stimulating factor and/or erythropoietin.
Topics: Anemia; Animals; Blood Cell Count; Blood Platelets; Bone Marrow Transplantation; Erythropoietin; Granulocyte Colony-Stimulating Factor; Guanidines; Hematopoiesis; Immunosuppressive Agents; Interleukin-3; Leukopenia; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Thrombopoietin; Transplantation Chimera | 1994 |
Improvement of mitomycin C- and cyclophosphamide-induced thrombocytopenia and leucocytopenia by prior treatment with deoxyspergualin in dogs.
Topics: Animals; Cyclophosphamide; Dogs; Guanidines; Immunosuppressive Agents; Leukocyte Count; Leukopenia; Male; Mitomycin; Thrombocytopenia | 1994 |